Astec LifeSciences Limited
Astec Lifesciences Limited will hold a board meeting on April 27, 2026, to consider and approve its audited yearly standalone and cons. financial results for the fiscal year ended March 31, 2026. The trading window for the company's shares is closed from April 1 to April 29, 2026.
Apr 17 2026 22:04:00
Astec LifeSciences Limited
Astec Lifesciences Limited will hold a board meeting on April 27, 2026, to consider and approve its audited yearly standalone and cons. financial results for the fiscal year ended March 31, 2026. The trading window for the company's shares is closed from April 1 to April 29, 2026.
Apr 17 2026 22:04:00
Astec LifeSciences Limited
Astec Lifesciences Limited will hold a board meeting on April 27, 2026, to consider and approve its audited yearly standalone and cons. financial results for the fiscal year ended March 31, 2026. The trading window for the company's shares is closed from April 1 to April 29, 2026.
Apr 17 2026 22:04:00
Astec Lifesciences Ltd - 533138 - Board Meeting Intimation for Approval Of Financial Results
Astec LifeSciences board to meet on April 27, 2026, to consider and approve the standalone and consolidated audited financial results for Q4 FY26 and the financial year ended March 31, 2026. These results will be reviewed by the Audit Committee prior to the board meeting.
Apr 17 2026 22:04:00
Astec LifeSciences Limited
Astec LifeSciences board is scheduled to meet on April 27, 2026. The meeting will consider and approve the standalone and consolidated audited financial results for Q4 and FY26, after review by the Audit Committee.
Apr 17 2026 21:04:00
Astec LifeSciences Limited
Astec LifeSciences confirmed timely payment of ₹25 crore for its Commercial Paper, Astec-CP-188, ensuring compliance with its financial obligations. The payment was made on the maturity date of April 15, 2026.
Apr 15 2026 18:04:00
Astec LifeSciences Limited
Astec LifeSciences announced significant management changes. Burjis Godrej transitioned from his role as Managing Director to an Additional Director Non Executive, effective April 13, 2026. Concurrently, Arijit Mukherjee, the Chief Operating Officer, was formally appointed to his role, strengthening the operational leadership.
Apr 15 2026 15:04:00
Astec LifeSciences Limited
Astec LifeSciences board approved significant leadership changes. Nadir Godrej retired as Chairman, while Vishal Sharma was appointed as the new Chairman. Burjis N. Godrej resigned as MD but was re-appointed as Non-Executive Director, alongside new appointments Mathew Eipe and Arijit Mukherjee.
Apr 13 2026 21:04:00
Astec LifeSciences Limited
Astec LifeSciences board approved significant leadership changes. Nadir Godrej retired as Chairman, while Vishal Sharma was appointed as the new Chairman. Burjis N. Godrej resigned as MD but was re-appointed as Non-Executive Director, alongside new appointments Mathew Eipe and Arijit Mukherjee.
Apr 13 2026 21:04:00
Astec LifeSciences Limited
Astec LifeSciences announced significant board changes effective April 13, 2026, including Nadir Godrej's retirement as Chairperson and the appointment of Vishal Sharma to lead the board. Burjis N. Godrej stepped down as MD but will continue as a Non-Executive Director, alongside Arijit Mukherjee's new role as Executive Director & COO, pending shareholder approval.
Apr 13 2026 18:04:00
Read More